EOLS – Evolus, Inc.
Float Short %
22.72
Margin Of Safety %
Put/Call OI Ratio
0.04
EPS Next Q Diff
0.17
EPS Last/This Y
0.42
EPS This/Next Y
0.6
Price
6.85
Target Price
18.5
Analyst Recom
1.29
Performance Q
-9.99
Relative Volume
0.5
Beta
0.92
Ticker: EOLS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-10 | EOLS | 7.05 | 0.03 | 0.41 | 19570 |
| 2025-11-11 | EOLS | 6.97 | 0.03 | 0.00 | 19558 |
| 2025-11-12 | EOLS | 7.29 | 0.03 | 0.95 | 19550 |
| 2025-11-13 | EOLS | 7.36 | 0.03 | 0.01 | 19555 |
| 2025-11-14 | EOLS | 7.22 | 0.03 | 0.03 | 19651 |
| 2025-11-17 | EOLS | 6.95 | 0.03 | 0.14 | 19560 |
| 2025-11-18 | EOLS | 7.03 | 0.03 | 0.02 | 19511 |
| 2025-11-19 | EOLS | 6.78 | 0.03 | 0.01 | 19516 |
| 2025-11-20 | EOLS | 6.63 | 0.03 | 0.04 | 19596 |
| 2025-11-21 | EOLS | 6.86 | 0.02 | 0.00 | 19409 |
| 2025-11-24 | EOLS | 6.76 | 0.03 | 0.00 | 8653 |
| 2025-11-25 | EOLS | 6.97 | 0.03 | 0.00 | 8679 |
| 2025-11-26 | EOLS | 7.03 | 0.03 | 0.00 | 8689 |
| 2025-12-01 | EOLS | 6.84 | 0.03 | 0.00 | 8707 |
| 2025-12-02 | EOLS | 6.53 | 0.03 | 0.08 | 8705 |
| 2025-12-03 | EOLS | 6.75 | 0.03 | 0.03 | 8724 |
| 2025-12-04 | EOLS | 6.83 | 0.03 | 3.64 | 8754 |
| 2025-12-05 | EOLS | 6.86 | 0.04 | 0.00 | 8752 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-11-10 | EOLS | 7.05 | 331.7 | 50.4 | -0.57 |
| 2025-11-11 | EOLS | 6.99 | 331.7 | 36.6 | -0.35 |
| 2025-11-12 | EOLS | 7.30 | 331.7 | 36.5 | -0.35 |
| 2025-11-13 | EOLS | 7.36 | 331.7 | 36.5 | -0.35 |
| 2025-11-14 | EOLS | 7.20 | 403.6 | 36.6 | -0.35 |
| 2025-11-17 | EOLS | 6.95 | 403.6 | 36.6 | -0.35 |
| 2025-11-18 | EOLS | 7.04 | 403.6 | 36.5 | -0.35 |
| 2025-11-19 | EOLS | 6.78 | 403.6 | 36.6 | -0.35 |
| 2025-11-20 | EOLS | 6.62 | 403.6 | 36.6 | -0.35 |
| 2025-11-21 | EOLS | 6.86 | 302.9 | 36.5 | -0.39 |
| 2025-11-24 | EOLS | 6.76 | 302.9 | 36.6 | -0.39 |
| 2025-11-25 | EOLS | 6.98 | 302.9 | 36.5 | -0.39 |
| 2025-11-26 | EOLS | 7.04 | 302.9 | 36.5 | -0.39 |
| 2025-12-01 | EOLS | 6.84 | 302.9 | 36.6 | -0.39 |
| 2025-12-02 | EOLS | 6.52 | 302.9 | 36.6 | -0.39 |
| 2025-12-03 | EOLS | 6.75 | 302.9 | 36.5 | -0.39 |
| 2025-12-04 | EOLS | 6.82 | 302.9 | 36.5 | -0.39 |
| 2025-12-05 | EOLS | 6.85 | 302.9 | 36.5 | -0.39 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-11-10 | EOLS | -0.78 | 4.81 | 26.04 |
| 2025-11-11 | EOLS | -0.78 | 4.81 | 26.04 |
| 2025-11-12 | EOLS | -0.78 | 4.81 | 26.05 |
| 2025-11-13 | EOLS | -0.78 | 4.81 | 26.05 |
| 2025-11-14 | EOLS | -0.78 | 4.81 | 26.05 |
| 2025-11-17 | EOLS | -0.60 | 11.63 | 26.05 |
| 2025-11-18 | EOLS | -0.60 | 11.63 | 26.05 |
| 2025-11-19 | EOLS | -0.60 | 11.63 | 26.05 |
| 2025-11-20 | EOLS | -0.60 | 11.63 | 26.05 |
| 2025-11-21 | EOLS | -0.60 | 11.63 | 26.70 |
| 2025-11-24 | EOLS | -0.55 | -9.32 | 26.70 |
| 2025-11-25 | EOLS | -0.55 | -9.32 | 26.70 |
| 2025-11-26 | EOLS | -0.55 | -9.32 | 22.72 |
| 2025-12-01 | EOLS | -0.55 | -9.23 | 22.72 |
| 2025-12-02 | EOLS | -0.55 | -9.23 | 22.72 |
| 2025-12-03 | EOLS | -0.55 | -9.23 | 22.72 |
| 2025-12-04 | EOLS | -0.55 | -9.23 | 22.72 |
| 2025-12-05 | EOLS | -0.55 | -9.23 | 22.72 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.2
Avg. EPS Est. Current Quarter
0.06
Avg. EPS Est. Next Quarter
-0.03
Insider Transactions
-0.55
Institutional Transactions
-9.23
Beta
0.92
Average Sales Estimate Current Quarter
91
Average Sales Estimate Next Quarter
80
Fair Value
Quality Score
30
Growth Score
51
Sentiment Score
2
Actual DrawDown %
61.6
Max Drawdown 5-Year %
-68.4
Target Price
18.5
P/E
Forward P/E
36.14
PEG
P/S
1.55
P/B
P/Free Cash Flow
EPS
-0.91
Average EPS Est. Cur. Y
-0.39
EPS Next Y. (Est.)
0.21
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-20.49
Relative Volume
0.5
Return on Equity vs Sector %
176.7
Return on Equity vs Industry %
196.2
EPS 1 7Days Diff
EPS 1 30Days Diff
0.17
EBIT Estimation
36.5
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 329
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading